1.1. Executive Summary: Global Brain Health Supplements Market

2.1. Research Objective

2.2. Product Overview

2.3. Market Segmentation
2.4. Qualitative Research
2.4.1. Primary & Secondary Sources

2.5. Quantitative Research
2.5.1. Primary & Secondary Sources

2.6. Breakdown of Primary Research Respondents, By Region

2.7. Assumption for Study

2.8. Market Size Estimation

2.9. Data Triangulation

3.1. Industry Value Chain Analysis
3.1.1. Raw Material Suppliers (Herbal Extracts, Vitamins, Minerals)
3.1.2. Ingredient Manufacturers
3.1.3. Supplement Manufacturers (Formulators & OEMs)
3.1.4. Distributors & Retail Channels
3.1.5. Online Platforms & E-commerce
3.1.6. Healthcare Professionals & Pharmacies
3.1.7. End Users (Consumers)

3.2. Industry Outlook
3.2.1. Rising Prevalence of Cognitive Disorders
3.2.2. Increasing Awareness of Mental Health & Brain Wellness
3.2.3. Growing Aging Population
3.2.4. Rising Demand for Preventive Healthcare
3.2.5. Expansion of Nutraceutical Industry
3.2.6. Growth in E-commerce & Direct-to-Consumer Sales
3.2.7. Increasing Adoption of Herbal & Natural Supplements
3.2.8. Rising Investment in R&D and Product Innovation

3.3. PESTLE Analysis
3.4. Porter's Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitutes
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition

3.5. Market Dynamics and Trends
3.5.1. Growth Drivers
3.5.1.1. Rising Awareness of Cognitive Health & Mental Wellness
3.5.2. Restraints
3.5.3. Opportunity
3.5.4. Key Trend

3.6. Market Growth and Outlook
3.6.1. Market Revenue Estimates and Forecast (US$ Mn), 2020 – 2035
3.6.2. Price Trend Analysis, 

4.1. Market Concentration Rate
4.2. Company Market Share Analysis (Value %), 2025
4.3. Competitor Mapping & Benchmarking
4.4. Startup Ecosystem Analysis
4.5. M&A and Funding Landscape

5.1. Key Insights

5.2. Market Size and Forecast, 2020-2035 (US$ Mn)
5.2.1. By Product 
5.2.1.1. Natural Molecules
5.2.1.1.1. Acetyl-L-Carnitine
5.2.1.1.2. Alpha GPC
5.2.1.1.3. Citicoline
5.2.1.1.4. DHA
5.2.1.1.5. Pre/Pro/Postbiotics
5.2.1.2. Herbal Extract
5.2.1.2.1. Curcumin
5.2.1.2.2. Ginseng
5.2.1.2.3. Gingko Biloba
5.2.1.2.4. Others
5.2.1.3. Vitamins and Minerals
5.2.1.3.1. Vitamin B
5.2.1.3.2. Vitamin C & E
5.2.2. By Application
5.2.2.1. Attention & Focus
5.2.2.2. Memory Enhancement
5.2.2.3. Sleep Recovery
5.2.2.4. Stress & Anxiety
5.2.2.5. Anti-Ageing & Longevity
5.2.2.6. Depression & Mood
5.2.3. By Sales Channel
5.2.3.1. Drug Stores
5.2.3.2. Supermarkets
5.2.3.3. Online Stores
5.2.3.4. Others
5.2.4. By Region
5.2.4.1. North America
5.2.4.1.1. The U.S.
5.2.4.1.2. Canada
5.2.4.1.3. Mexico
5.2.4.2. Europe
5.2.4.2.1. Western Europe
5.2.4.2.1.1. The UK
5.2.4.2.1.2. Germany
5.2.4.2.1.3. France
5.2.4.2.1.4. Italy
5.2.4.2.1.5. Spain
5.2.4.2.1.6. Rest of Western Europe
5.2.4.2.2. Eastern Europe
5.2.4.2.2.1. Poland 
5.2.4.2.2.2. Russia
5.2.4.2.2.3. Rest of Eastern Europe
5.2.4.3. Asia Pacific
5.2.4.3.1. China
5.2.4.3.2. India
5.2.4.3.3. Japan
5.2.4.3.4. South Korea
5.2.4.3.5. Australia & New Zealand
5.2.4.3.6. ASEAN
5.2.4.3.6.1. Indonesia  
5.2.4.3.6.2. Malaysia  
5.2.4.3.6.3. Thailand 
5.2.4.3.6.4. Singapore 
5.2.4.3.6.5. Rest of ASEAN 
5.2.4.3.7. Rest of Asia Pacific
5.2.4.4. Middle East & Africa
5.2.4.4.1. UAE
5.2.4.4.2. Saudi Arabia
5.2.4.4.3. South Africa
5.2.4.4.4. Rest of MEA
5.2.4.5. South America
5.2.4.5.1. Argentina
5.2.4.5.2. Brazil
5.2.4.5.3. Rest of South America

6.1. Market Dynamics and Trends
6.1.1. Growth Drivers 
6.1.2. Restraints 
6.1.3. Opportunity 
6.1.4. Key Trends 

6.2. Market Size and Forecast, 2020-2035 (US$ Mn)
6.2.1. By Product
6.2.2. By Application
6.2.3. By Sales Channel
6.2.4. By Country

7.1. Market Dynamics and Trends
7.1.1. Growth Drivers 
7.1.2. Restraints 
7.1.3. Opportunity 
7.1.4. Key Trends 

7.2. Market Size and Forecast, 2020-2035 (US$ Mn)
7.2.1. By Product
7.2.2. By Application
7.2.3. By Sales Channel
7.2.4. By Country

8.1. Market Dynamics and Trends
8.1.1. Growth Drivers 
8.1.2. Restraints 
8.1.3. Opportunity 
8.1.4. Key Trends 
 

8.2. Market Size and Forecast, 2020-2035 (US$ Mn)
8.2.1. By Product
8.2.2. By Application
8.2.3. By Sales Channel
8.2.4. By Country

9.1. Market Dynamics and Trends
9.1.1. Growth Drivers 
9.1.2. Restraints 
9.1.3. Opportunity 
9.1.4. Key Trends 
9.2. Market Size and Forecast, 2020-2035 (US$ Mn)
9.2.1. By Product
9.2.2. By Application
9.2.3. By Sales Channel
9.2.4. By Country

10.1. Market Dynamics and Trends
10.1.1. Growth Drivers 
10.1.2. Restraints 
10.1.3. Opportunity 
10.1.4. Key Trends 

10.2. Market Size and Forecast, 2020-2035 (US$ Mn)
10.2.1. By Product
10.2.2. By Application
10.2.3. By Sales Channel
10.2.4. By Country

11.1. Accelerated Intelligence Inc
11.2. AlternaScript LLC
11.3. Aurobindo Pharma Limited (Natroll, LLC)
11.4. HVMN Inc
11.5. Intelligent Labs
11.6. KeyView Labs, Inc
11.7. Liquid Health, Inc
11.8. Natural Factors Nutritional Products Ltd
11.9. NOW Foods
11.10. Onnit Labs, LLC
11.11. Peak Nootropics
11.12. Purelife Bioscience Co., Ltd
11.13. Quincy Bioscience, LLC
11.14. Reckitt Benckiser Group plc
11.15. Teva Pharmaceutical Industries Ltd
11.16.  Other Prominent Players

12.1. List of Secondary Sources
12.2. Macro-Economic Outlook/Indicators